肾病综合征中糖皮质激素的给药 - Suppr

Suppr

超能文献

Dosing of glucocorticosteroids in nephrotic syndrome.

作者信息

Mehls Otto, Hoyer Peter F

机构信息

University Hospital for Children and Adolescents, Heidelberg, 69120, Germany.

出版信息

Pediatr Nephrol. 2011 Dec;26(12):2095-8. doi: 10.1007/s00467-011-1993-8. Epub 2011 Sep 9.

DOI:10.1007/s00467-011-1993-8

PMID:21904778

Abstract

摘要

相似文献

Dosing of glucocorticosteroids in nephrotic syndrome.

Pediatr Nephrol. 2011 Dec;26(12):2095-8. doi: 10.1007/s00467-011-1993-8. Epub 2011 Sep 9.

Weight dosing of steroids in nephrotic syndrome.

Pediatr Nephrol. 2012 Mar;27(3):505. doi: 10.1007/s00467-011-2091-7. Epub 2011 Dec 31.

Dosing of steroids in small children with nephrotic syndrome.

Pediatr Nephrol. 2014 Feb;29(2):327. doi: 10.1007/s00467-013-2418-7. Epub 2013 Feb 6.

Two dosing regimens for steroid therapy in nephrotic syndrome.

Pediatr Nephrol. 2014 Feb;29(2):325. doi: 10.1007/s00467-013-2417-8. Epub 2013 Feb 6.

Weight or body surface area dosing of steroids in nephrotic syndrome: is there an outcome difference?

Pediatr Nephrol. 2011 Dec;26(12):2167-71. doi: 10.1007/s00467-011-1961-3. Epub 2011 Jul 16.

[Therapeutic approaches of nephrotic syndrome in children at the beginning of the XXI century].

Nefrologia. 2003 Jul-Aug;23(4):287-90.

Lower prednisone dosing for steroid-sensitive nephrotic syndrome relapse: a prospective randomized pilot study.

Eur J Pediatr. 2020 Feb;179(2):279-283. doi: 10.1007/s00431-019-03506-5. Epub 2019 Nov 14.

Prednisone dosing per body weight or body surface area in children with nephrotic syndrome: is it equivalent?

Pediatr Nephrol. 2009 May;24(5):1027-31. doi: 10.1007/s00467-008-1089-2. Epub 2009 Jan 23.

Efficacy of body weight vs body surface area-based prednisolone regimen in nephrotic syndrome.

Clin Exp Nephrol. 2020 Jul;24(7):622-629. doi: 10.1007/s10157-020-01875-y. Epub 2020 Mar 22.

[Assessment on application of Chinese herbs in process of corticosterone reduction in nephrotic syndrome].

Zhongguo Zhong Xi Yi Jie He Za Zhi. 2000 Oct;20(10):725-6, 773.

引用本文的文献

Treatment of idiopathic nephrotic syndrome with two steroid dosing regimens - one-year observational study.

Cent Eur J Immunol. 2021;46(3):344-350. doi: 10.5114/ceji.2021.109720. Epub 2021 Oct 6.

Update on the treatment of steroid-sensitive nephrotic syndrome.

Pediatr Nephrol. 2022 Feb;37(2):303-314. doi: 10.1007/s00467-021-04983-3. Epub 2021 Mar 5.

Optimizing the corticosteroid dose in steroid-sensitive nephrotic syndrome.

Pediatr Nephrol. 2022 Jan;37(1):37-47. doi: 10.1007/s00467-021-04985-1. Epub 2021 Feb 20.

Lower prednisone dosing for steroid-sensitive nephrotic syndrome relapse: a prospective randomized pilot study.

Eur J Pediatr. 2020 Feb;179(2):279-283. doi: 10.1007/s00431-019-03506-5. Epub 2019 Nov 14.

The Italian Society for Pediatric Nephrology (SINePe) consensus document on the management of nephrotic syndrome in children: Part I - Diagnosis and treatment of the first episode and the first relapse.

Ital J Pediatr. 2017 Apr 21;43(1):41. doi: 10.1186/s13052-017-0356-x.

Body weight-based prednisolone versus body surface area-based prednisolone regimen for induction of remission in children with nephrotic syndrome: a randomized, open-label, equivalence clinical trial.

Pediatr Nephrol. 2016 Apr;31(4):595-604. doi: 10.1007/s00467-015-3285-1. Epub 2016 Jan 12.

Corticosteroid therapy for nephrotic syndrome in children.

Cochrane Database Syst Rev. 2015 Mar 18;2015(3):CD001533. doi: 10.1002/14651858.CD001533.pub5.

Two dosing regimens for steroid therapy in nephrotic syndrome.

Pediatr Nephrol. 2014 Feb;29(2):325. doi: 10.1007/s00467-013-2417-8. Epub 2013 Feb 6.

Weight dosing of steroids in nephrotic syndrome.

Pediatr Nephrol. 2012 Mar;27(3):505. doi: 10.1007/s00467-011-2091-7. Epub 2011 Dec 31.

本文引用的文献

Weight or body surface area dosing of steroids in nephrotic syndrome: is there an outcome difference?

Pediatr Nephrol. 2011 Dec;26(12):2167-71. doi: 10.1007/s00467-011-1961-3. Epub 2011 Jul 16.

Physiopathology of idiopathic nephrotic syndrome: lessons from glucocorticoids and epigenetic perspectives.

Pediatr Nephrol. 2012 Aug;27(8):1249-56. doi: 10.1007/s00467-011-1947-1. Epub 2011 Jun 28.

Serum regulates cortisol bioactivity by corticosteroid-binding globulin-dependent and independent mechanisms, as revealed by combined bioassay and physicochemical assay approaches.

Clin Endocrinol (Oxf). 2011 Jul;75(1):31-8. doi: 10.1111/j.1365-2265.2011.04003.x.

Stimulation of the calcium-sensing receptor stabilizes the podocyte cytoskeleton, improves cell survival, and reduces toxin-induced glomerulosclerosis.

Kidney Int. 2011 Sep;80(5):483-92. doi: 10.1038/ki.2011.105. Epub 2011 Apr 20.

Establishing a sensitive and specific assay for determination of glucocorticoid bioactivity.

Wien Klin Wochenschr. 2011 Apr;123(7-8):222-9. doi: 10.1007/s00508-011-1562-y. Epub 2011 Apr 7.

Rapid non-genomic effects of corticosteroids and their role in the central stress response.

J Endocrinol. 2011 May;209(2):153-67. doi: 10.1530/JOE-10-0472. Epub 2011 Feb 28.

Glucocorticoid resistance.

Endocr Dev. 2011;20:127-136. doi: 10.1159/000321234. Epub 2010 Dec 16.

Interventions for idiopathic steroid-resistant nephrotic syndrome in children.

Cochrane Database Syst Rev. 2010 Nov 10(11):CD003594. doi: 10.1002/14651858.CD003594.pub4.

Minimal change disease: a "two-hit" podocyte immune disorder?

Pediatr Nephrol. 2011 Apr;26(4):645-9. doi: 10.1007/s00467-010-1676-x. Epub 2010 Oct 30.

Circulating permeability factors in idiopathic nephrotic syndrome and focal segmental glomerulosclerosis.

Clin J Am Soc Nephrol. 2010 Nov;5(11):2115-21. doi: 10.2215/CJN.03800609. Epub 2010 Oct 21.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Dosing of glucocorticosteroids in nephrotic syndrome.

作者信息

Mehls Otto, Hoyer Peter F

机构信息

University Hospital for Children and Adolescents, Heidelberg, 69120, Germany.

出版信息

Pediatr Nephrol. 2011 Dec;26(12):2095-8. doi: 10.1007/s00467-011-1993-8. Epub 2011 Sep 9.

DOI:10.1007/s00467-011-1993-8

PMID:21904778

Abstract

摘要

相似文献

Dosing of glucocorticosteroids in nephrotic syndrome.

Pediatr Nephrol. 2011 Dec;26(12):2095-8. doi: 10.1007/s00467-011-1993-8. Epub 2011 Sep 9.

Weight dosing of steroids in nephrotic syndrome.

Pediatr Nephrol. 2012 Mar;27(3):505. doi: 10.1007/s00467-011-2091-7. Epub 2011 Dec 31.

Dosing of steroids in small children with nephrotic syndrome.

Pediatr Nephrol. 2014 Feb;29(2):327. doi: 10.1007/s00467-013-2418-7. Epub 2013 Feb 6.

Two dosing regimens for steroid therapy in nephrotic syndrome.

Pediatr Nephrol. 2014 Feb;29(2):325. doi: 10.1007/s00467-013-2417-8. Epub 2013 Feb 6.

Weight or body surface area dosing of steroids in nephrotic syndrome: is there an outcome difference?

Pediatr Nephrol. 2011 Dec;26(12):2167-71. doi: 10.1007/s00467-011-1961-3. Epub 2011 Jul 16.

[Therapeutic approaches of nephrotic syndrome in children at the beginning of the XXI century].

Nefrologia. 2003 Jul-Aug;23(4):287-90.

Lower prednisone dosing for steroid-sensitive nephrotic syndrome relapse: a prospective randomized pilot study.

Eur J Pediatr. 2020 Feb;179(2):279-283. doi: 10.1007/s00431-019-03506-5. Epub 2019 Nov 14.

Prednisone dosing per body weight or body surface area in children with nephrotic syndrome: is it equivalent?

Pediatr Nephrol. 2009 May;24(5):1027-31. doi: 10.1007/s00467-008-1089-2. Epub 2009 Jan 23.

Efficacy of body weight vs body surface area-based prednisolone regimen in nephrotic syndrome.

Clin Exp Nephrol. 2020 Jul;24(7):622-629. doi: 10.1007/s10157-020-01875-y. Epub 2020 Mar 22.

[Assessment on application of Chinese herbs in process of corticosterone reduction in nephrotic syndrome].

Zhongguo Zhong Xi Yi Jie He Za Zhi. 2000 Oct;20(10):725-6, 773.

引用本文的文献

Treatment of idiopathic nephrotic syndrome with two steroid dosing regimens - one-year observational study.

Cent Eur J Immunol. 2021;46(3):344-350. doi: 10.5114/ceji.2021.109720. Epub 2021 Oct 6.

Update on the treatment of steroid-sensitive nephrotic syndrome.

Pediatr Nephrol. 2022 Feb;37(2):303-314. doi: 10.1007/s00467-021-04983-3. Epub 2021 Mar 5.

Optimizing the corticosteroid dose in steroid-sensitive nephrotic syndrome.

Pediatr Nephrol. 2022 Jan;37(1):37-47. doi: 10.1007/s00467-021-04985-1. Epub 2021 Feb 20.

Lower prednisone dosing for steroid-sensitive nephrotic syndrome relapse: a prospective randomized pilot study.

Eur J Pediatr. 2020 Feb;179(2):279-283. doi: 10.1007/s00431-019-03506-5. Epub 2019 Nov 14.

Ital J Pediatr. 2017 Apr 21;43(1):41. doi: 10.1186/s13052-017-0356-x.

Pediatr Nephrol. 2016 Apr;31(4):595-604. doi: 10.1007/s00467-015-3285-1. Epub 2016 Jan 12.

Corticosteroid therapy for nephrotic syndrome in children.

Cochrane Database Syst Rev. 2015 Mar 18;2015(3):CD001533. doi: 10.1002/14651858.CD001533.pub5.

Two dosing regimens for steroid therapy in nephrotic syndrome.

Pediatr Nephrol. 2014 Feb;29(2):325. doi: 10.1007/s00467-013-2417-8. Epub 2013 Feb 6.

Weight dosing of steroids in nephrotic syndrome.

Pediatr Nephrol. 2012 Mar;27(3):505. doi: 10.1007/s00467-011-2091-7. Epub 2011 Dec 31.

本文引用的文献

Weight or body surface area dosing of steroids in nephrotic syndrome: is there an outcome difference?

Pediatr Nephrol. 2011 Dec;26(12):2167-71. doi: 10.1007/s00467-011-1961-3. Epub 2011 Jul 16.

Physiopathology of idiopathic nephrotic syndrome: lessons from glucocorticoids and epigenetic perspectives.

Pediatr Nephrol. 2012 Aug;27(8):1249-56. doi: 10.1007/s00467-011-1947-1. Epub 2011 Jun 28.

Serum regulates cortisol bioactivity by corticosteroid-binding globulin-dependent and independent mechanisms, as revealed by combined bioassay and physicochemical assay approaches.

Clin Endocrinol (Oxf). 2011 Jul;75(1):31-8. doi: 10.1111/j.1365-2265.2011.04003.x.

Stimulation of the calcium-sensing receptor stabilizes the podocyte cytoskeleton, improves cell survival, and reduces toxin-induced glomerulosclerosis.

Kidney Int. 2011 Sep;80(5):483-92. doi: 10.1038/ki.2011.105. Epub 2011 Apr 20.

Establishing a sensitive and specific assay for determination of glucocorticoid bioactivity.

Wien Klin Wochenschr. 2011 Apr;123(7-8):222-9. doi: 10.1007/s00508-011-1562-y. Epub 2011 Apr 7.

Rapid non-genomic effects of corticosteroids and their role in the central stress response.

J Endocrinol. 2011 May;209(2):153-67. doi: 10.1530/JOE-10-0472. Epub 2011 Feb 28.

Glucocorticoid resistance.

Endocr Dev. 2011;20:127-136. doi: 10.1159/000321234. Epub 2010 Dec 16.

Interventions for idiopathic steroid-resistant nephrotic syndrome in children.

Cochrane Database Syst Rev. 2010 Nov 10(11):CD003594. doi: 10.1002/14651858.CD003594.pub4.

Minimal change disease: a "two-hit" podocyte immune disorder?

Pediatr Nephrol. 2011 Apr;26(4):645-9. doi: 10.1007/s00467-010-1676-x. Epub 2010 Oct 30.

Circulating permeability factors in idiopathic nephrotic syndrome and focal segmental glomerulosclerosis.

Clin J Am Soc Nephrol. 2010 Nov;5(11):2115-21. doi: 10.2215/CJN.03800609. Epub 2010 Oct 21.